Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

TREZIX⢠Capsules | Trezix

14:27 EDT 18th April 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Acetaminophen, Caffeine and Dihydrocodeine Bitartrate           CIII

320.5 mg / 30 mg / 16 mg Rx Only

IMAGE Acetaminophen.jpgIMAGE Caffeine.jpgIMAGE Dihydrocodeine_Bitartrate.jpg

Geriatric Use: TREZIX™ capsules should be given with caution to the elderly.

Hepatic Impairment: TREZIX™ capsules should be given with caution to patients with hepatic insufficiency. Since dihydrocodeine is metabolized by the liver and since acetaminophen potentially causes hepatotoxicity, the effects of this combination product should be monitored closely in such patients.

Renal Impairment: TREZIX™ capsules should be used with caution and at reduced dosage in the presence of impaired renal function.

WraSer PHARMACEUTICALS

NDC 66992-340-10

TREZIX® CIII

(acetaminophen, caffeine and dihydrocodeine*bitartrate capsules 320.5mg/30mg/16mg)

HepatotoxicityAcetaminophen has been associated with cases of acute liverfailure, at times resulting in liver transplant and death. Most ofthe cases of liver injury are associated with the use of acetaminophenat doses that exceed 4000 milligrams per day, and ofteninvolve more than one acetaminophen containing product.

Rx ONLY

*WARNING: May be habit-forming.

100 CAPSULES

Manufacturer

WraSer LLC

Active Ingredients

Source

Drugs and Medications [0 Results]

None

Clinical Trials [0 Results]

None

PubMed Articles [0 Results]

None

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement